BioNTech SE (BNTX) Total Liabilities (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Total Liabilities data on file, last reported at $3.2 billion in Q4 2025.

• In Q4 2025, Total Liabilities fell 3.44% year-over-year to $3.2 billion; the TTM figure through Dec 2025 stood at $3.2 billion (down 3.44% YoY), while the FY2025 annual figure was $3.1 billion, down 6.28% from the prior year.
• Total Liabilities slipped to $3.2 billion in Q4 2025, from $3.3 billion in the prior quarter.
• Across five years, Total Liabilities topped out at $6.5 billion in Q3 2021 and bottomed at $7.0 million in Q4 2021.
• A 5-year average of $3.3 billion and a median of $3.3 billion in 2022 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2021 — Total Liabilities sank 99.38% — and 2022, when it soared 47029.01%.
• Year by year, Total Liabilities stood at $7.0 million in 2021, then soared by 47029.01% to $3.3 billion in 2022, then retreated by 9.69% to $3.0 billion in 2023, then advanced by 12.21% to $3.3 billion in 2024, then dropped by 3.44% to $3.2 billion in 2025.
• The last three Total Liabilities figures came in at $3.2 billion (Q4 2025), $3.3 billion (Q3 2025), and $3.5 billion (Q2 2025), per Business Quant data.

Peer Comparison